← Back to All Filings

Vanguard Reports 0% Stake in Astera Labs Due to Internal Realignment

Low SignificanceMarch 26, 2026 at 4:09:54 PM EDT

Astera Labs, Inc.

$ALABSCHEDULE 13G/ACIK: 0001736297

Subscribe to track ALAB

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Reports 0% Stake in Astera Labs Due to Internal Realignment

Company: Astera Labs, Inc. (CIK: 0001736297) Form: SCHEDULE 13G/A | Filed: 2026/03/26 Significance: Low (Administrative)

Reporting Person: The Vanguard Group Type: Institutional Investment Manager

Filing Details: • Shares Reported: 0 • Percent of Class: 0% • Previous Status: Major Holder

Key Insight: Vanguard reports 0 shares owned directly due to an internal corporate realignment. Subsidiaries will now report beneficial ownership separately on a disaggregated basis. This does not necessarily indicate a market sell-off of the underlying shares.

Market Context: Astera Labs has a market cap of $19.75B. This filing is technical in nature regarding Vanguard's reporting structure.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Astera Labs, Inc.

Executive Summary

  • Trading Significance: Low (Administrative)
  • Key Takeaway: The Vanguard Group reports 0% ownership due to an internal realignment where subsidiaries now report separately; this is likely not a liquidation of position.
  • Market Impact: Neutral. The change is technical regarding SEC reporting compliance rather than a sentiment-driven exit.

Company Information

FieldValue
CompanyAstera Labs, Inc.
CIK0001736297
Market Cap$19.75 Billion
Shares Outstanding170,210,000

Insider Information

FieldValue
Reporting PersonThe Vanguard Group
CIK0000102909
TypeInstitutional Investment Manager
LocationMalvern, PA

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A (Amendment)
Filing Date2026/03/26
Shares Beneficially Owned0
Percent of Class0%
Voting Power0

Financial Impact Assessment

Transaction Materiality

  • Reported Holding: 0 shares (0% of outstanding)
  • Reason for Change: Internal Realignment (See Context below)
  • Market Cap Context: $19.75B Market Cap. While Vanguard is a massive holder, this specific zeroing out is procedural.

Impact Evaluation

  • Ownership Concentration: The filing indicates that The Vanguard Group parent entity no longer claims beneficial ownership. Ownership is now likely distributed across various Vanguard subsidiaries/funds which will file separately if they cross reporting thresholds.
  • Transaction Significance: Low. This is a change in who reports the shares (disaggregation), not necessarily a change in the aggregate number of shares held by Vanguard funds collectively.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The explanatory note explicitly states this is due to an internal realignment where subsidiaries will report separately. Algorithms might initially read "0%" as a dump, but human analysis confirms it is administrative.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Footnote Analysis: "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment... certain subsidiaries... will report beneficial ownership separately... The Vanguard Group, Inc. no longer has... beneficial ownership over securities beneficially owned by such subsidiaries."
  • Regulatory Context: This filing is made in reliance on SEC Release No. 34-39538 regarding disaggregated reporting for investment managers.
Topics:#AsteraLabs#Vanguard#SECFiling#InstitutionalOwnership#Form13G#MarketStructure#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.